Jara-Prado, Aurelio
Arias-Capistran, Eukeni
Guerrero-Camacho, Jorge
Ochoa-Morales, Adriana
Boll, Marie Catherine
Dávila-Ortíz de Montellano, David
Rasmussen, Astrid
Ashizawa, Tetsuo
Fernandez-Ruiz, Juan
Yescas-Gómez, Petra
Ramírez-García, Miguel Ángel https://orcid.org/0000-0003-3221-3636
Article History
Accepted: 31 December 2024
First Online: 16 January 2025
Declarations
:
: This research did not receive specific funding from any public, commercial, or not-for-profit funding agency.
: Tetsuo Ashizawa received grants from the NIH (U01 NS104326 and R01 NS115002), the National Ataxia Foundation, and the Myotonic Dystrophy Foundation. He discloses participation in Biogen trials NCT03952806 and Biohaven trials NCT03701399, and he received the endowment Harriet and Joe B. Foster Distinguished Chair in Neurosciences.